KFDA reported equivalent drug efficacy plan to MOHW

Published: 1999-06-29 10:23:00

Updated: 1999-06-29 10:23:00

The KFDA clarified that an encatment of the temporary special provision should be required for the equivalent drug efficacy verfication retroactive to all drugs the government already authorized if the government had to accept the civic group's proposals strongly suggested in line with the upcomi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK